Gallbladder carcinoma
MONDO:0003220A carcinoma that arises from epithelial cells of the gall bladder
Also known as: gallbladder cancer, Gall bladder carcinoma (adeno), Gall bladder carcinoma (adenocarcinoma), cancer of gallbladder, cancer of the gallbladder, carcinoma of gall bladder, carcinoma of gallbladder, carcinoma of the gallbladder
2913 clinical trials for this condition and its sub-types, 40 tagged with Gallbladder carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Gallbladder carcinoma
-
Gallbladder adenocarcinoma 9 trials
4 sub-types
-
Gall bladder carcinoma in situ 0 trials
-
Gallbladder squamous cell carcinoma 0 trials
1 sub-type
- Gallbladder adenosquamous carcinoma 0 trials
-
New drug combo tested for tough bile duct cancers
Disease control Stopped earlyThis study tested a new drug called LSTA1 added to standard treatment for people with advanced bile duct or gallbladder cancer. The goal was to see if the combination is safe and works better than standard treatment alone. The trial was stopped early, and results are not yet avai…
Phase 2 • Sponsor: Lisata Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New cancer drug trial halted early – what we know
Disease control Stopped earlyThis study tested a new drug, felmetatug vedotin, alone or with pembrolizumab, in people with advanced solid tumors like ovarian, breast, and lung cancer. The goal was to check safety and find the right dose. The trial was terminated early, so results are limited.
Phase 1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Experimental liver cancer drug shows promise in early trial
Disease control Stopped earlyThis phase 2 trial tested a drug called Taxoprexin (DHA-paclitaxel) in 13 people with advanced liver cancer that had not responded to prior treatments. The goal was to see if the drug could shrink tumors and how safe it was. The study was terminated early, so results are limited.
Phase 2 • Sponsor: American Regent, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Cancer gene hunt: could tumor maps guide better GI cancer treatment?
Knowledge-focused Stopped earlyThis study looked at genetic mutations in tumors from 565 people with advanced gastrointestinal cancers, including liver, bile duct, gallbladder, pancreas, esophagus, and stomach cancers. The goal was to see how often these mutations could be targeted by existing drugs and to tra…
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC